|
MNKKQ's Revenue Growth by Quarter and Year
Mallinckrodt Plc's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
MNKKQ Revenue (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
IV Quarter |
January |
-
|
597.20
|
682.80
|
804.90
|
III Quarter |
October |
-
|
507.20
|
698.30
|
743.70
|
II Quarter |
July |
-
|
546.40
|
166.50
|
823.30
|
I Quarter |
April |
490.90
|
558.00
|
665.80
|
790.60
|
FY |
|
490.90
|
2,208.80
|
2,213.40
|
3,162.50
|
MNKKQ Revenue first quarter 2022 Y/Y Growth Comment |
Mallinckrodt Plc reported fall in Revenue in the first quarter 2022 by -12.03% to $ 490.90 millions, from the same quarter in 2021. The decline in the first quarter 2022 Mallinckrodt Plc's Revenue compares unfavorably to the Company's average Revenue growth of 7.05%.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 192 other companies have achieved higher Revenue growth. While Mallinckrodt Plc' s Revenue decrease of -12.03% ranks overall at the positon no. 3336 in the first quarter 2022.
|
MNKKQ Revenue ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
January |
- |
-12.54 % |
-15.17 % |
-41.3 % |
III Quarter |
October |
- |
-27.37 % |
-6.1 % |
16.2 % |
II Quarter |
July |
- |
228.17 % |
-79.78 % |
30.33 % |
I Quarter |
April |
-12.03 % |
-16.19 % |
-15.79 % |
38.07 % |
FY |
|
- |
-0.21 % |
-30.01 % |
-1.65 % |
MNKKQ Revenue (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
IV Quarter |
January |
- |
17.74 % |
-2.22 % |
8.23 % |
III Quarter |
October |
- |
-7.17 % |
319.4 % |
-9.67 % |
II Quarter |
July |
- |
-2.08 % |
-74.99 % |
4.14 % |
I Quarter |
April |
-17.8 % |
-18.28 % |
-17.28 % |
-42.35 % |
FY (Year on Year) |
|
- |
-0.21 % |
-30.01 % |
-1.65 % |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
228.17 % |
7.05 % |
-79.78 % |
(Jun 25 2021) |
|
(Jun 26 2020) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
228.17 % |
7.05 % |
-79.78 % |
(Jun 25 2021) |
|
(Jun 26 2020) |
|
Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Mallinckrodt Plc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
319.4 % |
12.57 % |
-74.99 % |
(Sep 25 2020) |
|
|
MNKKQ's I. Quarter Q/Q Revenue Comment |
In the I. Quarter 2022 Mallinckrodt Plc realized fall in Revenue from the fourth quarter by -17.8% to $ 490.90 millions, from $ 597.20 millions achived in the previous reporting period.
But that's not huge issue, as Revenue frequently tend to slow in this quarter Aidan Hill, market veteran from Seattle wrote.
Within Major Pharmaceutical Preparations industry 188 other companies have achieved higher Revenue quarter on quarter growth. While Mallinckrodt Plc's Revenue growth quarter on quarter, overall rank is 3232. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
319.4 % |
12.57 % |
-74.99 % |
(Sep 25 2020) |
|
|
MNKKQ's I. Quarter Q/Q Revenue Comment |
In the I. Quarter 2022 Mallinckrodt Plc realized fall in Revenue sequentially by -17.8% to $ 490.90 millions, from $ 597.20 millions released a quarter before.
As we analyse recent downturn in the quarter, we suppose to presume, that frequently I. Quarter Revenue occur sluggish in contrast to the fourth quarter, Aidan Hill, market veteran from Seattle added.
Within Major Pharmaceutical Preparations industry 188 other companies have achieved higher Revenue quarter on quarter growth. While Mallinckrodt Plc's Revenue growth quarter on quarter, overall rank is 3232. |
|
Mallinckrodt Plc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Apr 01 2022) |
12 Months Ending (Dec 31 2021) |
12 Months Ending (Sep 24 2021) |
12 Months Ending (Jun 25 2021) |
12 Months Ending (Mar 26 2021) |
Cumulative Revenue 12 Months Ending |
$ 2,141.70 |
$ 2,208.80 |
$ 2,294.40 |
$ 2,485.50 |
$ 2,105.60 |
Y / Y Revenue Growth (TTM) |
1.71 % |
-0.21 % |
-1.76 % |
4.39 % |
-30.68 % |
Year on Year Revenue Growth Overall
Ranking |
# 721 |
# 2356 |
# 2052 |
# 2253 |
# 2851 |
Seqeuential Revenue Change (TTM) |
-3.04 % |
-3.73 % |
-7.69 % |
18.04 % |
-4.87 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 3160 |
# 2604 |
# 2530 |
# 607 |
# 3126 |
Cumulative Revenue growth
Comment |
Although Mallinckrodt Plc's Annual Revenue growth year on year were below company's average 1.96% , Revenue announced in the Apr 01 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.71% year on year, from -0.21% in Dec 31 2021.
In the Healthcare sector 61 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 721, from total ranking in previous quarter at 2356. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
120.71 % |
1.96 % |
-37.37 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
120.71 % |
1.96 % |
-37.37 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 146 |
Sector |
# 426 |
S&P 500 |
# 3160 |
|
Cumulative Revenue growth
Comment |
Although Mallinckrodt Plc's Annual Revenue growth year on year were below company's average 1.96% , Revenue announced in the Apr 01 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.71% year on year, from -0.21% in Dec 31 2021.
In the Healthcare sector 61 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 721, from total ranking in previous quarter at 2356. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
120.71 % |
1.96 % |
-37.37 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
120.71 % |
1.96 % |
-37.37 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 146 |
Sector |
# 426 |
S&P 500 |
# 3160 |
|